Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.

Marin P, Julve R, Chaves FJ, Giner V, Pascual JM, Armengod ME, Redon J.

J Hum Hypertens. 2004 Jan;18(1):25-31.

PMID:
14688807
2.

Body weight changes and the A-6G polymorphism of the angiotensinogen gene.

Chaves FJ, Giner V, Corella D, Pascual J, Marin P, Armengod ME, Redon J.

Int J Obes Relat Metab Disord. 2002 Sep;26(9):1173-8.

PMID:
12187393
3.

Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.

Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.

J Hypertens. 2006 Nov;24(11):2277-84.

PMID:
17053551
4.

Functional variants of the angiotensinogen gene determine antihypertensive responses to angiotensin-converting enzyme inhibitors in subjects of African origin.

Woodiwiss AJ, Nkeh B, Samani NJ, Badenhorst D, Maseko M, Tiago AD, Candy GP, Libhaber E, Sareli P, Brooksbank R, Norton GR.

J Hypertens. 2006 Jun;24(6):1057-64.

PMID:
16685205
5.

The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.

Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Stricker BH.

Eur J Hum Genet. 2006 Jul;14(7):860-6. Epub 2006 May 17.

7.

Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.

Jiang X, Sheng HH, Lin G, Li J, Lu XZ, Cheng YL, Huang J, Xiao HS, Zhan YY.

Chin Med J (Engl). 2007 May 5;120(9):782-6.

PMID:
17531119
8.

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.

Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.

Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. Epub 2005 Oct 20.

PMID:
16487914
9.

T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors.

Yu H, Lin S, Liu G, Zhang Y, Deng C, Ma W.

Hypertens Res. 2005 Dec;28(12):981-6.

PMID:
16671337
10.

Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.

Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.

Am J Hypertens. 1995 Aug;8(8):808-14.

PMID:
7576397
11.

Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.

Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G; BENEDICT Study Group.

J Am Soc Nephrol. 2006 Dec;17(12):3472-81. Epub 2006 Nov 2.

12.

[Insertion/deletion polymorphism of the gene encoding for angiotensin-converting enzyme and microalbuminuria in essential arterial hypertension].

Rovira E, Chaves FJ, Julve R, Pascual JM, Miralles A, Armengod ME, Redon J.

Med Clin (Barc). 1999 May 29;112(19):726-30. Spanish.

PMID:
10394569
13.

Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.

Schelleman H, Klungel OH, Witteman JC, Breteler MM, Yazdanpanah M, Danser AH, Hofman A, van Duijn CM, de Boer A, Stricker BH.

Eur J Hum Genet. 2007 Apr;15(4):478-84. Epub 2007 Feb 14.

14.

Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.

Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, Armengod ME, Cooper RS.

Hypertension. 2000 Jan;35(1 Pt 2):490-5.

PMID:
10642347
15.
16.

[The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].

Li NF, Zhou L, Wu WD, Shi Y, Wang XL, Wang J, Li HJ, Zhang DL, Zu H, Ouyang WJ, Bu KL, Zhou KM, Cheng QY, Guli N, Zhu DH.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Feb;21(1):23-8. Chinese.

PMID:
14767903
17.

Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.

Redon J, Rovira E, Miralles A, Julve R, Pascual JM.

Hypertension. 2002 Mar 1;39(3):794-8.

PMID:
11897766
18.

[Association of angiotensinogen gene M235T variant with essential hypertension].

Cai SY, Yu F, Shi YP.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Mar;33(2):151-4. Chinese.

PMID:
15067738
19.

[The AGT genotype affects the antihypertensive effects of benazepril].

Yu HM, Lin SG, Zhang YQ, Ma WJ, Liu GZ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Sep;33(9):819-23. Chinese.

PMID:
16266458
20.

[Factors associated with changes in microalbuminuria during antihypertensive treatment].

Rovira E, Julve R, Pascual JM, Miralles A, Redon J.

Med Clin (Barc). 2000 May 20;114(19):721-5. Spanish.

PMID:
10919124

Supplemental Content

Support Center